rs73983658

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_002230.4(JUP):​c.1653+10C>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00839 in 1,598,466 control chromosomes in the GnomAD database, including 934 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.043 ( 455 hom., cov: 32)
Exomes 𝑓: 0.0047 ( 479 hom. )

Consequence

JUP
NM_002230.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:12

Conservation

PhyloP100: 0.735
Variant links:
Genes affected
JUP (HGNC:6207): (junction plakoglobin) This gene encodes a major cytoplasmic protein which is the only known constituent common to submembranous plaques of both desmosomes and intermediate junctions. This protein forms distinct complexes with cadherins and desmosomal cadherins and is a member of the catenin family since it contains a distinct repeating amino acid motif called the armadillo repeat. Mutation in this gene has been associated with Naxos disease. Alternative splicing occurs in this gene; however, not all transcripts have been fully described. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79).
BP6
Variant 17-41758705-G-T is Benign according to our data. Variant chr17-41758705-G-T is described in ClinVar as [Benign]. Clinvar id is 45838.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-41758705-G-T is described in Lovd as [Benign]. Variant chr17-41758705-G-T is described in Lovd as [Likely_benign].
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.146 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
JUPNM_002230.4 linkuse as main transcriptc.1653+10C>A intron_variant ENST00000393931.8 NP_002221.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
JUPENST00000393931.8 linkuse as main transcriptc.1653+10C>A intron_variant 1 NM_002230.4 ENSP00000377508 P1
JUPENST00000310706.9 linkuse as main transcriptc.1653+10C>A intron_variant 1 ENSP00000311113 P1
JUPENST00000393930.5 linkuse as main transcriptc.1653+10C>A intron_variant 5 ENSP00000377507 P1
JUPENST00000585793.1 linkuse as main transcriptn.251+10C>A intron_variant, non_coding_transcript_variant 2

Frequencies

GnomAD3 genomes
AF:
0.0427
AC:
6501
AN:
152138
Hom.:
446
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.148
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0161
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00311
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.000456
Gnomad OTH
AF:
0.0301
GnomAD3 exomes
AF:
0.0111
AC:
2456
AN:
222132
Hom.:
172
AF XY:
0.00813
AC XY:
976
AN XY:
120084
show subpopulations
Gnomad AFR exome
AF:
0.154
Gnomad AMR exome
AF:
0.00590
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000181
Gnomad SAS exome
AF:
0.00237
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000434
Gnomad OTH exome
AF:
0.00683
GnomAD4 exome
AF:
0.00475
AC:
6865
AN:
1446210
Hom.:
479
Cov.:
32
AF XY:
0.00415
AC XY:
2983
AN XY:
718304
show subpopulations
Gnomad4 AFR exome
AF:
0.160
Gnomad4 AMR exome
AF:
0.00786
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.000129
Gnomad4 SAS exome
AF:
0.00185
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.000222
Gnomad4 OTH exome
AF:
0.0127
GnomAD4 genome
AF:
0.0430
AC:
6540
AN:
152256
Hom.:
455
Cov.:
32
AF XY:
0.0411
AC XY:
3057
AN XY:
74464
show subpopulations
Gnomad4 AFR
AF:
0.149
Gnomad4 AMR
AF:
0.0161
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.000193
Gnomad4 SAS
AF:
0.00269
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000456
Gnomad4 OTH
AF:
0.0350
Alfa
AF:
0.0377
Hom.:
112
Bravo
AF:
0.0489
Asia WGS
AF:
0.0480
AC:
166
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:12
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:5
Benign, no assertion criteria providedclinical testingClinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center-- -
Benign, no assertion criteria providedclinical testingClinical Genetics, Academic Medical Center-- -
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Benign, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineApr 24, 2012- -
Benign, no assertion criteria providedclinical testingGenome Diagnostics Laboratory, University Medical Center Utrecht-- -
not provided Benign:3
Benign, criteria provided, single submitterclinical testingGeneDxMar 03, 2015- -
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Likely benign, no assertion criteria providedclinical testingJoint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+-- -
Naxos disease Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Cardiomyopathy Benign:1
Benign, no assertion criteria providedclinical testingCohesion PhenomicsSep 23, 2022- -
Arrhythmogenic right ventricular dysplasia 12 Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Naxos disease;C1969081:Arrhythmogenic right ventricular dysplasia 12 Benign:1
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpFeb 01, 2024- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.79
CADD
Benign
13
DANN
Benign
0.72

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs73983658; hg19: chr17-39914957; API